Neo Ivy Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-350
| Closed | -$40.8K | – | 359 |
|
|
2025
Q1 | $40.8K | Buy |
+350
| New | +$40.8K | 0.01% | 248 |
|
|
2023
Q4 | – | Sell |
-2,912
| Closed | -$204K | – | 296 |
|
|
2023
Q3 | $204K | Buy |
+2,912
| New | +$204K | 0.09% | 226 |
|
|
2022
Q4 | – | Sell |
-225
| Closed | -$10K | – | 336 |
|
|
2022
Q3 | $10K | Buy |
+225
| New | +$10K | 0.03% | 320 |
|
|
2020
Q4 | – | Sell |
-950
| Closed | -$67K | – | 417 |
|
|
2020
Q3 | $67K | Buy |
+950
| New | +$67K | 0.07% | 334 |
|